XML 32 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 14 - Segment Information
9 Months Ended
Sep. 29, 2018
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]
1
4
.
Segment Information
 
The Company follows “Disclosures about Segments of an Enterprise and Related Information,” which establishes standards for companies to report information about operating segments, geographic areas and major customers. The accounting policies of each reportable segment are the same as those described in the summary of significant accounting policies (see Note
1
to the Company’s Consolidated Financial Statements included in its Annual Report on Form
10
-K for the year ended
December 30, 2017).
 
Segment operating income includes selling, general and administrative expenses directly attributable to that segment as well as charges for allocating corporate costs to each of the operating segments. The following tables reflect the results of the reportable segments consistent with the Company’s management system:
 
Thirteen
Week Period Ended
September 29, 2018
 
 
Engineering
   
Specialty
Health Care
   
Information
Technology
   
 
Corporate
   
 
Total
 
Revenue
  $
19,424
    $
15,106
    $
8,029
    $
-
    $
42,559
 
Cost of services
   
14,049
     
11,665
     
5,857
     
-
     
31,571
 
Gross profit
   
5,375
     
3,441
     
2,172
     
-
     
10,988
 
Selling, general and administrative
   
3,780
     
3,648
     
1,984
     
-
     
9,412
 
Depreciation and amortization
   
236
     
85
     
23
     
-
     
344
 
Operating income (loss)
  $
1,359
    $
(292
)
  $
165
    $
-
    $
1,232
 
                                         
Total assets as of September 29, 2018
  $
40,643
    $
18,874
    $
7,110
    $
6,801
    $
73,428
 
Capital expenditures
  $
465
    $
151
    $
90
    $
110
    $
816
 
 
 
Thirteen
Week Period Ended
September 30, 2017
 
 
Engineering
   
Specialty
Health Care
   
Information
Technology
   
 
Corporate
   
 
Total
 
Revenue
  $
21,708
    $
14,335
    $
7,784
    $
-
    $
43,827
 
Cost of services
   
15,533
     
10,805
     
5,771
     
-
     
32,109
 
Gross profit
   
6,175
     
3,530
     
2,013
     
-
     
11,718
 
Selling, general and administrative
   
3,968
     
3,750
     
1,982
     
-
     
9,700
 
Depreciation and amortization
   
297
     
86
     
39
     
-
     
422
 
Operating income (loss)
  $
1,910
    $
(306
)
  $
(8
)
  $
-
    $
1,596
 
                                         
Total assets as of September 30, 2017
  $
33,721
    $
16,178
    $
10,212
    $
3,937
    $
64,048
 
Capital expenditures
  $
138
    $
44
    $
-
    $
13
    $
195
 
 
Thirty-Nine
Week Period Ended
September 29, 2018
 
 
Engineering
   
Specialty
Health Care
   
Information
Technology
   
 
Corporate
   
 
Total
 
Revenue
  $
62,412
    $
60,599
    $
22,070
    $
-
    $
145,081
 
Cost of services
   
45,706
     
46,822
     
16,275
     
-
     
108,803
 
Gross profit
   
16,706
     
13,777
     
5,795
     
-
     
36,278
 
Selling, general and administrative
   
12,006
     
12,255
     
5,648
     
-
     
29,909
 
Depreciation and amortization
   
785
     
294
     
77
     
-
     
1,156
 
Severance, professional fees and other charges
   
-
     
-
     
-
     
1,371
     
1,371
 
Operating income (loss)
  $
3,915
    $
1,228
    $
70
    $
(1,371
)
  $
3,842
 
                                         
Total assets as of September 29, 2018
  $
40,643
    $
18,874
    $
7,110
    $
6,801
    $
73,428
 
Capital expenditures
  $
856
    $
207
    $
108
    $
243
    $
1,414
 
 
 
Thirty-Nine
Week Period Ended
September 30, 2017
 
 
Engineering
   
Specialty
Health Care
   
Information
Technology
   
 
Corporate
   
 
Total
 
Revenue
  $
61,517
    $
49,212
    $
24,951
    $
-
    $
135,680
 
Cost of services
   
44,598
     
37,069
     
18,430
     
-
     
100,097
 
Gross profit
   
16,919
     
12,143
     
6,521
     
-
     
35,583
 
Selling, general and administrative
   
12,184
     
11,429
     
6,479
     
-
     
30,092
 
Change in contingent consideration
   
-
     
-
     
-
     
781
     
781
 
Depreciation and amortization
   
863
     
246
     
120
     
-
     
1,229
 
Operating income (loss)
  $
3,872
    $
468
    $
(78
)
  $
(781
)
  $
3,481
 
                                         
Total assets as of September 30, 2017
  $
33,721
    $
16,178
    $
10,212
    $
3,937
    $
64,048
 
Capital expenditures
  $
247
    $
459
    $
-
    $
41
    $
747
 
 
The Company derives a majority of its revenue from offices in the United States. Revenues reported for each operating segment are all from external customers. The Company is domiciled in the United States and its segments operate in the United States, Canada, Puerto Rico and Serbia. Revenues by geographic area for the
thirty-nine
week periods ended
September 29, 2018
and
September 30, 2017
are as follows:
 
   
Thirteen Week Periods Ended
   
Thirty-Nine Week Periods Ended
 
   
September 29,
2018
   
September 30,
2017
   
September 29,
2018
   
September 30,
2017
 
Revenues
                               
U. S.
  $
34,729
    $
34,207
    $
118,364
    $
110,083
 
Canada
   
6,308
     
8,703
     
21,942
     
22,420
 
Puerto Rico
   
1,113
     
917
     
3,142
     
3,177
 
Serbia
   
409
     
-
     
1,633
     
-
 
    $
42,559
    $
43,827
    $
145,081
    $
135,680
 
 
Total assets by geographic area as of the reported periods are as follows:
 
   
September 29,
2018
   
December 30,
2017
 
Total assets                
U. S.
  $
50,309
    $
52,595
 
Canada
   
17,382
     
15,419
 
Puerto Rico
   
1,823
     
1,891
 
Serbia
   
3,914
     
3,374
 
    $
73,428
    $
73,279